Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

6.75USD
24 Jul 2014
Price Change (% chg)

$-0.11 (-1.60%)
Prev Close
$6.86
Open
$6.86
Day's High
$6.86
Day's Low
$6.74
Volume
10,997
Avg. Vol
30,410
52-wk High
$11.88
52-wk Low
$5.52

RGLS.OQ

Chart for RGLS.OQ

About

Regulus Therapeutics Inc., is a biopharmaceutical company focused on discovering and developing microRNAs to treat a range of diseases. microRNAs are naturally occurring ribonucleic acid (RNA), molecules that play a critical role in regulating key biological pathways. The Company uses its microRNA product platform to develop... (more)

Overall

Beta: --
Market Cap (Mil.): $297.43
Shares Outstanding (Mil.): 43.36
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 106.71 36.40
EPS (TTM): -0.60 -- --
ROI: -24.32 0.13 18.27
ROE: -32.64 -0.64 19.15
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks